To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cure Connections

Heather Ambrose, Martha Raymond, and Tim Wert recognize unmet needs in the management of patients diagnosed with GI cancers.
Heather Ambrose, Martha Raymond, and Tim Wert highlight the pharmaceutical industry’s investment in conducting research and clinical trials to improve the care of patients impacted by GI cancers.
Experts Heather Ambrose and Tim Wert define the pharmaceutical industry’s role in the GI cancer space and discuss strategies to address educational barriers between patients and physicians.
Sarah Bennett remarks on unmet needs specific to the cholangiocarcinoma community.

Cure Expert Connections

Heloisa P. Soares, MD, identifies recent advances that have been made in the treatment of neuroendocrine tumors and deliberates where the field is heading.
Heloisa P. Soares, MD, reflects on the prominence of quality of life and patient engagement in the context of neuroendocrine tumor management.
Heloisa P. Soares, MD, provides a comprehensive outline of available regimens for the management of neuroendocrine tumors, elucidating the value of somatostatin analogs.
Heloisa P. Soares, MD, shares insight on how to optimally initiate the treatment of neuroendocrine tumors and emphasizes the importance of seeing a specialist in this setting.

Cure TV

William G. Wierda, M.D., Ph.D.
William G. Wierda, M.D., Ph.D., medical director of the Leukemia Center at The University of Texas MD Anderson Cancer Center, discusses how to best combine and sequence therapies for patients with chronic lymphocytic leukemia (CLL).
Joshua Richter, M.D.
A new patient-reported outcomes tool is helping to shift the way end-of-life and depression-related conversations are occurring between patients with multiple myeloma and their health care teams.
Michael J. Overman, M.D.
Genetic testing – particularly for microsatellite instability (MSI) – is an important step for all patients diagnosed with colorectal cancer.
Tom Stockwell
Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable